Juno Lighting LLC (JUNO) Rating Reiterated by FBR & Co

Juno Lighting LLC (NASDAQ:JUNO)‘s stock had its “outperform” rating reiterated by investment analysts at FBR & Co in a research report issued on Saturday. They currently have a $61.00 price objective on the biopharmaceutical company’s stock. FBR & Co’s target price points to a potential upside of 117.86% from the company’s previous close.

Several other research analysts have also recently issued reports on the stock. Cowen and Company reissued a “buy” rating and set a $55.00 target price on shares of Juno Lighting in a report on Sunday, July 10th. Barclays PLC started coverage on shares of Juno Lighting in a report on Wednesday, July 6th. They set an “equal weight” rating and a $48.00 target price for the company. Maxim Group reissued a “buy” rating and set a $80.00 target price on shares of Juno Lighting in a report on Monday, July 18th. Leerink Swann reissued a “buy” rating and set a $86.00 target price on shares of Juno Lighting in a report on Thursday, July 14th. Finally, JPMorgan Chase & Co. lowered shares of Juno Lighting from an “overweight” rating to a “neutral” rating and dropped their price target for the company from $63.00 to $39.00 in a research report on Friday, July 8th. Two analysts have rated the stock with a sell rating, three have given a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company’s stock. Juno Lighting presently has a consensus rating of “Buy” and a consensus price target of $46.27.

Shares of Juno Lighting (NASDAQ:JUNO) opened at 27.99 on Friday. The firm has a 50-day moving average of $29.63 and a 200 day moving average of $35.80. Juno Lighting has a 52 week low of $22.37 and a 52 week high of $57.82. The stock’s market cap is $2.85 billion.

Juno Lighting (NASDAQ:JUNO) last issued its earnings results on Thursday, August 4th. The biopharmaceutical company reported ($0.64) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.41) by $0.23. The company had revenue of $27.60 million for the quarter, compared to analysts’ expectations of $14.26 million. During the same period in the previous year, the business posted ($0.35) earnings per share. Juno Lighting’s revenue was up 121.5% compared to the same quarter last year. On average, equities analysts forecast that Juno Lighting will post ($2.48) EPS for the current fiscal year.

In other news, CEO Hans Edgar Bishop sold 23,042 shares of Juno Lighting stock in a transaction dated Thursday, September 8th. The shares were sold at an average price of $30.06, for a total value of $692,642.52. Following the sale, the chief executive officer now owns 2,541,151 shares in the company, valued at $76,386,999.06. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Several hedge funds have recently made changes to their positions in JUNO. BlackRock Fund Advisors raised its position in Juno Lighting by 14.1% in the first quarter. BlackRock Fund Advisors now owns 1,517,425 shares of the biopharmaceutical company’s stock worth $57,799,000 after buying an additional 187,826 shares during the last quarter. Riverhead Capital Management LLC acquired a new position in Juno Lighting during the first quarter worth $2,845,000. BlackRock Group LTD raised its position in Juno Lighting by 15.3% in the first quarter. BlackRock Group LTD now owns 34,653 shares of the biopharmaceutical company’s stock worth $1,320,000 after buying an additional 4,609 shares during the last quarter. Bellevue Group AG acquired a new position in Juno Lighting during the first quarter worth $1,409,000. Finally, DekaBank Deutsche Girozentrale raised its position in Juno Lighting by 27.1% in the second quarter. DekaBank Deutsche Girozentrale now owns 60,000 shares of the biopharmaceutical company’s stock worth $2,374,000 after buying an additional 12,800 shares during the last quarter.